Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model

Ramsey, S. D. et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22, 382–387 (1999).

Han, G. & Ceilley, R. Chronic wound healing: a review of current management and treatments. Adv. Ther. 34, 599–610 (2017).

Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G. & Apelqvist, J. The global burden of diabetic foot disease. Lancet 366, 1719–1724 (2005).

Fetterolf, D. E., Istwan, N. B. & Stanziano, G. J. An evaluation of healing metrics associated with commonly used advanced wound care products for the treatment of chronic diabetic foot ulcers. Manag. Care. 23, 31–38 (2014).

Kavitha, K. V. et al. Choice of wound care in diabetic foot ulcer: a practical approach. World J. Diabetes 5, 546–556 (2014).

Trieb, K. The Charcot foot: pathophysiology, diagnosis and classification. Bone Joint J. 98-B, 1155–1159 (2016).

Hwang, D. J. et al. Association between diabetic foot ulcer and diabetic retinopathy. PLoS ONE 12, e0175270 (2017).

Bowering, C. K. Diabetic foot ulcers. Pathophysiology, assessment, and therapy. Can. Fam. Physician 47, 1007–1016 (2001).

Kota, S. K., Meher, L. K., Jammula, S., Krishna, S. V. & Modi, K. D. Aberrant angiogenesis: the gateway to diabetic complications. Indian J. Endocrinol. Metab. 16, 918–930 (2012).

Brem, H. et al. Wound-healing protocols for diabetic foot and pressure ulcers. Surg. Technol. Int. 11, 85–92 (2003).

Issan, Y. et al. Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axis. Can. J. Cardiol. 28, 728–736 (2012).

Zubiri, I. et al. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes. Transl. Res. 166, 474–484 (2015). e474.

Arun, P., Aleti, V., Parikh, K., Manne, V. & Chilukuri, N. Senescence marker protein 30 (SMP30) expression in eukaryotic cells: existence of multiple species and membrane localization. PLoS ONE 6, e16545 (2011).

Yamauchi, H. et al. Senescence marker protein-30 deficiency impairs angiogenesis under ischemia. Free Radic. Biol. Med. 94, 66–73 (2016).

Long, M. et al. An essential role of NRF2 in diabetic wound healing. Diabetes 65, 780–793 (2016).

Kensler, T. W., Wakabayashi, N. & Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89–116 (2007).

Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291–13295 (2009).

Kolluru, G. K., Bir, S. C. & Kevil, C. G. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 918267 (2012).

Xu, X. et al. Genetic variants of nuclear factor erythroid-derived 2-like 2 associated with the complications in Han descents with type 2 diabetes mellitus of Northeast China. J. Cell. Mol. Med. 20, 2078–2088 (2016).

Massee, M. et al. Type I and II diabetic adipose-derived stem cells respond in vitro to dehydrated human amnion/chorion membrane allograft treatment by increasing proliferation, migration, and altering cytokine secretion. Adv. Wound Care 5, 43–54 (2016).

Garcia-Contreras, M., Vera-Donoso, C. D., Hernandez-Andreu, J. M., Garcia-Verdugo, J. M. & Oltra, E. Therapeutic potential of human adipose-derived stem cells (ADSCs) from cancer patients: a pilot study. PLoS ONE 9, e113288 (2014).

Yuan, Y. et al. Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1alpha pathway. Clin. Sci. 130, 2181–2198 (2016).

Hu, L. et al. Exosomes derived from human adipose mensenchymal stem cells accelerates cutaneous wound healing via optimizing the characteristics of fibroblasts. Sci. Rep. 6, 32993 (2016).

Wu, K. et al. The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway. Am. J. Physiol. Endocrinol. Metab. 310, E828–837 (2016).

Meng, S. et al. Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3. PLoS ONE 8, e68611 (2013).

Zhao, L. et al. Exosomes derived from human pulmonary artery endothelial cells shift the balance between proliferation and apoptosis of smooth muscle cells. Cardiology 137, 43–53 (2017).

Shi, R. et al. Localization of human adipose-derived stem cells and their effect in repair of diabetic foot ulcers in rats. Stem Cell Res. Ther. 7, 155 (2016).

Edmonds, M. E., Foster, A. V. & McColgan, M. ‘Dermagraft’: a new treatment for diabetic foot ulcers. Diabet. Med. 14, 1010–1011 (1997).

Ruszkowska-Ciastek, B. et al. A preliminary evaluation of VEGF-A, VEGFR1 and VEGFR2 in patients with well-controlled type 2 diabetes mellitus. J. Zhejiang. Univ. Sci. B 15, 575–581 (2014).

Issan, Y. et al. Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins Other Lipid Mediat. 100-101, 15–21 (2013).

Zhou, L. et al. High glucose induces renal tubular epithelial injury via Sirt1/NF-kappaB/microR-29/Keap1 signal pathway. J. Transl. Med. 13, 352 (2015).

Fu, C., Li, B., Sun, Y., Ma, G. & Yao, Y. Bradykinin inhibits oxidative stress-induced senescence of endothelial progenitor cells through the B2R/AKT/RB and B2R/EGFR/RB signal pathways. Oncotarget 6, 24675–24689 (2015).

Zhang, J. et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling. Int. J. Biol. Sci. 12, 1472–1487 (2016).

Guo, S. C. et al. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics 7, 81–96 (2017).

Ma, K. et al. Nuclear accumulation of Yes-Associated Protein (YAP) maintains the survival of doxorubicin-induced senescent cells by promoting survivin expression. Cancer Lett. 375, 84–91 (2016).

Suthar, M., Gupta, S., Bukhari, S. & Ponemone, V. Treatment of chronic non-healing ulcers using autologous platelet rich plasma: a case series. J. Biomed. Sci. 24, 16 (2017).

Tao, S. C. et al. Chitosan wound dressings incorporating exosomes derived from microRNA-126-overexpressing synovium mesenchymal stem cells provide sustained release of exosomes and heal full-thickness skin defects in a diabetic rat model. Stem Cells Transl. Med. 6, 736–747 (2017).

Jang, J., Wang, Y., Kim, H. S., Lalli, M. A. & Kosik, K. S. Nrf2, a regulator of the proteasome, controls self-renewal and pluripotency in human embryonic stem cells. Stem Cells 32, 2616–2625 (2014).

Zheng, H. et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 60, 3055–3066 (2011).

Jiang, T. et al. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59, 850–860 (2010).